Tirzepatide Weight Management in Brownwood & Early, TX

Tirzepatide is a dual GIP and GLP-1 receptor agonist used in certain FDA-approved medications for chronic weight management and type 2 diabetes. It works with pathways involved in appetite, food intake and blood sugar regulation.

For weight management, tirzepatide can help reduce appetite, increase feelings of fullness and decrease food intake. At BioEnve, treatment is individualized and medically supervised based on your health history, treatment response, tolerability and goals.

Tirzepatide and semaglutide are both medications used for weight management in appropriate patients, but they work differently. Semaglutide acts on the GLP-1 receptor, while tirzepatide acts on both GIP and GLP-1 receptors.

Both medications can help reduce appetite, increase feelings of fullness and support significant weight reduction when combined with nutrition, physical activity and ongoing medical care. Individual response can vary, and one medication may be more appropriate than the other depending on your health history, treatment response, tolerability and goals.

Your BioEnve provider can help determine which option may be appropriate for you.

The most common side effects of tirzepatide are primarily gastrointestinal and may include nausea, diarrhea, vomiting, constipation, abdominal pain and indigestion. Other possible side effects may include injection-site reactions, fatigue, heartburn, belching, hair loss and allergic reactions.

Side effects vary from person to person and may be more noticeable when treatment begins or when the dose is increased.

More serious risks can include severe gastrointestinal reactions, dehydration that may affect kidney function, gallbladder problems, pancreatitis, serious allergic reactions and low blood sugar, particularly when tirzepatide is used with certain diabetes medications.

Your BioEnve provider will review your medical history and medications and monitor your response and tolerability throughout treatment. Contact your healthcare provider promptly if you experience severe or persistent symptoms.

Tirzepatide is not appropriate for everyone. It should not be used by patients with a personal or family history of medullary thyroid carcinoma (MTC), patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or patients who have had a serious allergic reaction to tirzepatide or any ingredient in their prescribed medication.

Tirzepatide is not recommended during pregnancy and should be discontinued if pregnancy occurs. Patients should also tell their provider about a history of pancreatitis, gallbladder disease, kidney problems, severe gastrointestinal problems such as gastroparesis, diabetes or diabetic retinopathy, and all medications they currently take.

Tirzepatide can also affect the absorption of oral medications. Women using oral birth-control pills should discuss contraception with their provider because additional or alternative contraception may be recommended after starting tirzepatide and after dose increases.

Your BioEnve provider will review your medical history, medications and individual risk factors to determine whether tirzepatide is appropriate for you.

Once you are evaluated by one of our providers, the medication will be ordered through our practice and shipped directly to our office for pick-up.

Your tirzepatide weight management program begins with a medical consultation. Your BioEnve provider will review your health history, current medications, vital signs, weight-related concerns and other relevant information to determine whether tirzepatide may be appropriate for you. Appropriate lab testing may also be recommended.

If tirzepatide is prescribed, your provider will develop an individualized treatment plan and provide instructions for your medication. Follow-up visits allow us to monitor your progress, treatment response, tolerability and any necessary adjustments throughout your weight-management journey.

Tirzepatide is injected under the skin (subQ) in your stomach, thigh, or upper arm one time each week, on the same day each week at any time of day.

How much Tirzepatide do I inject?

Patients will begin with the lowest recommended dose titrating up as tolerance grows. 

Injections will be administered once weekly.

Emsculpt can help optimize the benefits of Tirzepatide and Super Slim shots in the following ways:

1. Muscle toning: Emsculpt can target specific muscle groups and induce powerful muscle contractions, helping to tone and strengthen those muscles. This can complement the weight loss effects of Tirzepatide and Super Slim shots by improving overall body composition and enhancing muscle definition.

2. Metabolism boost: Emsculpt's intense muscle contractions stimulate a metabolic response in the body, leading to an increase in calorie burn. This can support the weight loss effects of Tirzepatide and Super Slim shots by further boosting the metabolic rate and aiding in fat reduction.

3. Enhanced fat reduction: In addition to muscle toning, Emsculpt has been shown to contribute to fat reduction. The intense muscle contractions break down surrounding fat cells, resulting in a reduction of fat in the treated area. This can complement the fat-burning effects of Tirzepatide and Super Slim shots, optimizing overall body contouring and weight loss results.

4. Improved body composition: Tirzepatide and Super Slim shots primarily aid in weight loss, but they may not directly target specific areas for toning and sculpting. Emsculpt can help by specifically targeting muscle groups and promoting muscle definition, resulting in a more toned and proportionate physique. This combination can optimize the overall aesthetic results of Tirzepatide and Super Slim shots.

5. Motivation and adherence: Seeing visible improvements in muscle tone and body composition through Emsculpt can provide motivation and adherence to your weight loss journey. The combination of Tirzepatide, Super Slim shots, and Emsculpt can help you stay committed to your goals and maintain a healthy lifestyle. This can optimize the benefits of all three treatments.